Revolution Medicines, Inc. (29) | Business Operations (2)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on February 3, 2020)
- Collaborative Research, Development and Commercialization Agreement, dated as of June 8, 2018, by and between Revolution Medicines, Inc. and Aventis, Inc., as amended (Filed With SEC on January 17, 2020)
